Our investors
Powering biology’s century with radically faster, more reliable clinical trials.
The “bottleneck” to delivering new medicines is the traditional, outdated ways clinical trials are run. Cutting edge therapies can’t get to patients until we collect the data needed to prove they work. We are passionate about using the highest quality scientific methods available to conduct radically faster, more reliable clinical trials.
Run your trial with one partner, instead of going through the pain of stitching together multiple solutions. From design and recruitment, to data collection and delivery, we’ll be by your side from start to finish.
We provide a clinical operations team consistently ranked best in industry for responsiveness and quality of execution who are assigned to your team based on extensive experience relevant to your trial.
And to make everything even smoother, our end-to-end technology platform covers all your clinical software and tool needs. Our technology supercharges studies to deliver faster study startups and recruitment timelines.
And to make everything even smoother, our end-to-end technology platform covers all your clinical software and tool needs. Our technology supercharges studies to deliver faster study startups and recruitment timelines.
Our Name
We’re named after James Lind who pioneered the first clinical trial in the 18th century and discovered that oranges and lemons cured scurvy. Like James, we’re pushing the frontiers of clinical research.
We’re a diverse team combining clinicians, scientists, technologists, and — clinical trial participants, all on a mission to improve the clinical research experience and build a better clinical research organization.
Leadership
%20(1).png)
.png)
.png)
Robert Langer
Shawn Treweek
Carel le Roux
Ready to enjoy working with your CRO?
Let’s deliver better clinical trials together to get new treatments to patients faster.
Ready to enjoy working with your CRO?
Let’s deliver better clinical trials together to get new treatments to patients faster.
